FDA Orders Manufacturers Of Surgical Mesh For Pelvic Organ Prolapse To Cease Sales And Distribution
On April 16, 2019, the U.S. Food and Drug Administration (FDA) ordered the manufacturers of all remaining surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse (POP) to immediately stop selling and distributing their products in the United States. The manufacturers, B[...]